Concepedia

Robert Nshimiyimana

RN

Statistics

Publications

12

Citations

313

H-Index

11

Active since

2017

Affiliations

Harvard University(Current)

Brigham and Women's Hospital

University of Southern California

Louisiana State University Health Sciences Center New Orleans

Cayman Chemical (United States)

Robert Nshimiyimana is an author at Harvard University specializing in inflammation, medicine, and inflammatory response regulation.

ORCID

Publications per year

2017–2024

12

Publications

12

Elovanoids counteract oligomeric β-amyloid-induced gene expression and protect photoreceptors

Khanh Do, Marie‐Audrey I. Kautzmann, Bokkyoo Jun et al. · Proceedings of the National Academy of Sciences · 2019 · 74 citations · Full text

, , +17

A New E-Series Resolvin: RvE4 Stereochemistry and Function in Efferocytosis of Inflammation-Resolution

Stephania Libreros, Ashley E. Shay, Robert Nshimiyimana et al. · Frontiers in Immunology · 2021 · 72 citations · Full text

, , +17

Human leukocytes selectively convert 4 <i>S</i> ,5 <i>S</i> -epoxy-resolvin to resolvin D3, resolvin D4, and a cys-resolvin isomer

Ashley E. Shay, Robert Nshimiyimana, Bengt Samuelsson et al. · Proceedings of the National Academy of Sciences · 2021 · 30 citations · Full text

, , +14

Infectious neutrophil deployment is regulated by resolvin D4

Stephania Libreros, Robert Nshimiyimana, Brendon Lee et al. · Blood · 2023 · 24 citations · Full text

, , +14

Stereospecific Metabolism of R- and S-Warfarin by Human Hepatic Cytosolic Reductases

Dustyn A. Barnette, Bryce P. Johnson, Dakota L. Pouncey et al. · Drug Metabolism and Disposition · 2017 · 18 citations · Full text

, , +17

1–5 of 12